|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.32 CNY | -0.58% |
|
-1.81% | -5.84% |
| 04-19 | Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-10 | Fangsheng Pharma's Factories Pass GMP Inspection | MT |
Changsha Baoyuan Traditional Chinese Medicine Co., Ltd announced that it will receive CNY 9 million in an equity round of funding from an existing investor, Hunan Fangsheng Pharmaceutical Co., Ltd. on January 24, 2015. The transaction has been approved at 19th emergency session of the 2nd directorate meeting. The investor will maintain its stake at 100% in the company.
Upon closing, the company will have a registered capital of CNY 10 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -5.84% | 628M | |
| +21.80% | 43.81B | |
| +29.63% | 23.03B | |
| +21.32% | 15.45B | |
| +19.05% | 14.4B | |
| +58.92% | 12.95B | |
| -0.05% | 6.79B | |
| -11.71% | 6.49B | |
| -8.87% | 5.73B | |
| +14.11% | 5.49B |
HUNAN FANGSHENG PHARMACEUTICAL CO., LTD. 
